EP Patent

EP3019243A4 — Methods for treating or preventing ophthalmological conditions

Assigned to Iveric Bio Inc · Expires 2017-03-15 · 9y expired

What this patent protects

Patent listed against avacincaptad-pegol-sodium.

Drugs covered by this patent

avacincaptad-pegol-sodium (AVACINCAPTAD PEGOL SODIUM)

Patent Metadata

Patent number: EP3019243A4
Jurisdiction: EP
Classification: —
Expires: 2017-03-15
Drug substance claim: No
Drug product claim: No
Assignee: Iveric Bio Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.